Additionally, Eomes+T-betlow CD8 T cells exhibit functional impairment in leukaemia patients, partly attributable to Eomes binding to the promoter of the inhibitory receptor TIGIT and positively regulating its expression (52). This evidence concerns the gene EOMES and leukemia.